BEAT

0.275110.94%
PJ

Peter J. Fitzgerald

Member of Scientific Advisory Board & Chief Medical Advisor

Dr. Peter J. Fitzgerald, M.D., Ph.D., FACC is Director of 19Labs, Inc. and Director of FEMSelect Inc. Dr. Fitzgerald is Advisor at Teal-Ventures. He has been a Member of the Advisory Board at PyrAmes Inc. He serves as Chief Medical Advisor at HeartBeam, Inc. since September 2025 and served as its Chief Medical Officer since October 2022 until September 2025 and serves as its Member of Scientific Advisory Board since November 9, 2023. He serves as a General Partner and Venture Consultant of Latterell Venture Partners. Dr. Fitzgerald is the Chief Advisor at iXensor Co., Ltd. since 2022. He was Chairman of iXensor Co., Ltd. since 2022 and serves as its Director. He serves as Independent Director at Deerfield Healthcare Technology Acquisitions Corp. since July 16, 2020. He served as a Director of CathWorks Ltd. Dr. Fitzgerald serves as an Advisor of CardioMind, Inc. Dr. Fitzgerald serves as a Medical Venture Partner and Advisor of BioStar Ventures. Dr. Fitzgerald Co-founded TriVentures 2009 and is its Managing Partner. He heads the US Triventures office. He is a Co-founder of Ensure Medical, Inc. Dr. Fitzgerald serves as a Scientific and Clinical Advisor of De Novo (formerly known as Saratoga Ventures, L.P.). He serves as a General Partner and previously served as an Investment Professional at TransPacific Venture Partners. He has been Principle/Founder of eighteen medical device companies in the San Francisco Bay Area. He has transitioned twelve of these start-ups to large medical device companies. In 2001, he was on the founding team of LVP Capital. Dr. Fitzgerald co-founded TransPacific Venture Partners and Latterell Venture Partners. Dr. Fitzgerald serves as Honorary Adjunct Professor at Stanford University. Dr. Fitzgerald serves as a Director of the Interventional Cardiology Research Laboratory at Stanford Medical School. He has been an Associate Professor of Medicine (Cardiology) since 1999, Associate Professor of Electrical Engineering since 1994 at Stanford University School of Medicine. He was Co-Director of the Center for Research in Cardiovascular Interventions from 1994 until 2004. From 2004 until 2018, Dr. Fitzgerald serves as a Director of the Center for Cardiovascular Technology and Director of the Core Cardiovascular Analysis Lab at Stanford University Medical Center since 1997. He serves as Program Host for the Stanford-Taiwan Biomedical Fellowship Program and has coached and trained Taiwan biomedical innovation and entrepreneurship talents for years. He runs the leading IVUS core lab for cardiovascular clinical trials and is the Principal and Founder of several medical device companies in the San Francisco Bay area. Dr. Fitzgerald contributes his clinical and engineering skills along with years of medical device startup experience to FEMSelect Inc. on a part-time basis while maintaining his full-time duties. He was the Co-founder of BioDesign and ioAsia Innovation Programs. Dr. Fitzgerald served as a Principal or Founder at eight medical device companies in the San Francisco Bay Area. Dr. Fitzgerald's broad clinical experience includes intravascular ultrasound, two-dimensional, color flow and Doppler echocardiography. He is a Board Member of Day Zero Diagnostics, Inc. Dr. Fitzgerald served as Medical Director of Corindus Vascular Robotics Inc. He is a Director of Genoox. He served as Medical Advisor of CardioOptics, Inc. Dr. Fitzgerald served as an Advisor of Cytograft Tissue Engineering Inc. He served as a Co-chief Medical Advisor of Cardiac Business at Novadaq Technologies Inc. since November 1, 2005 and served as its Consultant. He served as the Chief Medical Director of Theragenics Corp. since January 23, 2007. He has extensive venture and start-up experience of the fund is part of the founding team of more than a dozen medical device start-ups. His research is focused on signal and image processing of intravascular ultrasound for plaque characterization and advanced engineering developments in signal processing and catheter device development. He served as Scientific Advisor of CryoVascular Systems, Inc. Dr. Fitzgerald is a professor in the Department of Medicine and Engineering at Stanford. He was an Assistant Professor of Medicine (Cardiology) at Stanford University School of Medicine from 1994 to 1998; Research Assistant of Physiology and Engineering at Stanford University, from 1980 to 1982, Resident in Medicine at University of California, San Francisco, from 1987 to 1989; and a Cardiology Fellow in University of California, San Francisco, from 1989 to 1993. Dr. Fitzgerald serves as a Consultant and Medical/Advisory Board Member for several biomedical device and health companies in and around the San Francisco Bay Area. He has been principle/founder of 18 healthcare companies in Silicon Valley, has transitioned 13 of these start-ups to medium/large-cap life science companies and remains on several of their advisory boards. He also have been one of the principle founders of two healthcare-focused venture capital fund in Silicon Valley and Israel. He advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in cardiology, neurology, orthopedics and other areas. He advised include Abbott Vascular Devices, Boston Scientific, Cordis Corporation, Medtronic, St. Jude Medical, EV3 and Volcano Corporation. He serves as a Member of the Advisory Board at MitrAssist Medical Ltd. He has been a Member of the Medical Advisory Board of ReCor Medical, Inc., since September 2012. Dr. Fitzgerald serves as a Director of OrthoSpace Ltd. and AngioSlide, Ltd. Dr. Fitzgerald serves on the Medical Device Advisory Panel at the FDA. He also serves as a Consultant for Digital Medicine at the FDA. He serves as a Member of the Clinical and Scientific Advisory Board of FlowMedica, Inc. He serves as a Member of the Advisory Board of Percardia, Inc. He serves as a Member of the Scientific Advisory Board at Virtual Sourcing, Inc, MitralSolutions, Inc., Conor Medsystems, LLC and Prescient Medical, Inc. He serves as a Director at MitralSolutions, Inc. He serves as a Member of the Medical Advisory Board of X-Cell Medical, Inc., Palmaz Scientific Inc. and M.S.T. - Medical Surgical Technologies, Ltd. He serves on the Medical Advisory Boards of PanGenex Corporation, Boston Scientific Corporation, AVE/Medtronics, Pharmasonics Inc., A-Med Systems, Endosonics Corporation, Embolx Systems, Exponent Systems, IRL/Jomed (Europe), Rubicore Medical, Point Biomedical Systems, Mill Valley Medial Devices, Odessey Systems, Pathway Medical Technology, Fox Hollow Technology, SmithKline Beecham Corporation, Lumed Technologies, Yiftee, MicroHelix Systems, Advanced Stent Technologies, Transvascular Inc., Indec Systems, MediVasc Inc., AngioSense Inc., EndoTex Systems, Medical Technology Group, TIMI 3 Systems, PharmaSpec Inc., IMETRx, Phamacyclics, LibraMed, Cytograph Engineering, Planet-well.com, Cardio

Positions